• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎的风险因素、临床病程和长期预后:一项横断面研究。

Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study.

机构信息

Department of Dermatology, Health Sciences Faculty, Roskilde Hospital, University of Copenhagen, Copenhagen, Denmark.

出版信息

Br J Dermatol. 2014 Oct;171(4):819-24. doi: 10.1111/bjd.13090. Epub 2014 Sep 7.

DOI:10.1111/bjd.13090
PMID:24804604
Abstract

BACKGROUND

Hidradenitis suppurativa (HS) causes considerable morbidity. The long-term prognosis is of obvious interest to both patients and physicians. We conducted this study to determine the prognosis and risk factors in patients diagnosed with HS.

OBJECTIVES

To describe the long-term prognosis and the clinical course of HS and its association to known risk factors.

METHODS

A postal follow-up survey with uncomplicated factual questions was conducted. As all of the patients were well acquainted with their long-standing disease, this was thought to be sufficient for meaningful results. All cases were diagnosed by a dermatologist. Overall, 212 patients diagnosed with HS between 1981 and 2001 were studied after a median follow-up period of 22 years (range 12-32).

RESULTS

The overall response rate was 71.2%, with 60.8% (129/212) valid (fully completed) questionnaires. Remission was reported by 39.4% (50/127) and improvement by 31.5% (40/127). Unchanged severity was reported by 20.5% (26/127), and 8.7% (11/127) experienced worsening disease. Tobacco smoking was reported by 92.2% (119/129). Among nonsmokers, 40% (35/88) reported remission vs. 29% (17/59) of active smokers. A higher proportion of nonobese patients (45%) reported remission than obese patients (23%).

CONCLUSIONS

We found that 39.4% of the sample reported remission of HS. Suspected risk factors appeared to influence the prognosis. Smoking and obesity were significantly linked to a lower rate of self-reported remission. The notion that lifestyle factors play a role in HS appears to be supported by this survey.

摘要

背景

化脓性汗腺炎(HS)可导致相当大的发病率。长期预后对患者和医生都具有明显的意义。我们进行这项研究旨在确定患有 HS 的患者的预后和危险因素。

目的

描述 HS 的长期预后和临床过程及其与已知危险因素的关联。

方法

进行了一项邮寄随访调查,其中包含简单的事实问题。由于所有患者都非常了解自己的长期疾病,因此认为这足以获得有意义的结果。所有病例均由皮肤科医生诊断。总体而言,在中位随访 22 年(范围 12-32 年)后,研究了 1981 年至 2001 年间诊断为 HS 的 212 例患者。

结果

总应答率为 71.2%,212 例患者中有 60.8%(129/212)有效(完整填写)的调查问卷。39.4%(50/127)报告缓解,31.5%(40/127)报告改善。20.5%(26/127)报告病情无变化,8.7%(11/127)报告病情恶化。92.2%(119/127)报告吸烟。在不吸烟者中,40%(35/88)报告缓解,而吸烟者中为 29%(17/59)。非肥胖患者(45%)报告缓解的比例高于肥胖患者(23%)。

结论

我们发现,样本中有 39.4%的患者报告 HS 缓解。疑似危险因素似乎影响预后。吸烟和肥胖与自我报告缓解的比例降低显著相关。这项调查似乎支持生活方式因素在 HS 中起作用的观点。

相似文献

1
Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study.化脓性汗腺炎的风险因素、临床病程和长期预后:一项横断面研究。
Br J Dermatol. 2014 Oct;171(4):819-24. doi: 10.1111/bjd.13090. Epub 2014 Sep 7.
2
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.评估化脓性汗腺炎中反映吸烟和肥胖作用的客观指标。
Br J Dermatol. 2009 Oct;161(4):831-9. doi: 10.1111/j.1365-2133.2009.09198.x. Epub 2009 Apr 29.
3
Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.化脓性汗腺炎(HS)与社会经济地位(SES)低有关:一项横断面参考研究。
J Am Acad Dermatol. 2016 Oct;75(4):755-759.e1. doi: 10.1016/j.jaad.2016.04.067. Epub 2016 Jul 21.
4
The influence of body weight on the prevalence and severity of hidradenitis suppurativa.体重对化脓性汗腺炎患病率及严重程度的影响。
Acta Derm Venereol. 2014 Sep;94(5):553-7. doi: 10.2340/00015555-1800.
5
Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study.化脓性汗腺炎(HS)在澳大利亚的流行情况、人口统计学特征和管理途径:一项基于人群的横断面研究。
PLoS One. 2018 Jul 24;13(7):e0200683. doi: 10.1371/journal.pone.0200683. eCollection 2018.
6
Gallstones are associated with hidradenitis suppurativa: a population-based and hospital-based cross-sectional study from Denmark.胆结石与化脓性汗腺炎相关:一项基于丹麦人群和医院的横断面研究。
Eur J Gastroenterol Hepatol. 2015 Dec;27(12):1392-8. doi: 10.1097/MEG.0000000000000469.
7
Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.美国化脓性汗腺炎患者 2 型糖尿病的患病率。
J Am Acad Dermatol. 2018 Jul;79(1):71-76. doi: 10.1016/j.jaad.2018.01.014. Epub 2018 Jan 12.
8
Hidradenitis Suppurativa in Sweden: A Registry-Based Cross-Sectional Study of 13,538 Patients.瑞典化脓性汗腺炎:基于登记的 13538 例患者的横断面研究。
Dermatology. 2020;236(4):281-288. doi: 10.1159/000505545. Epub 2020 Feb 3.
9
A Population- and Hospital-based Cross-sectional Study of Renal Function in Hidradenitis Suppurativa.一项基于人群和医院的化脓性汗腺炎肾功能横断面研究。
Acta Derm Venereol. 2016 Jan;96(1):68-71. doi: 10.2340/00015555-2072.
10
Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.化脓性汗腺炎是一种系统性疾病,具有较大的合并症负担:基于图表验证的病例对照分析。
J Am Acad Dermatol. 2014 Dec;71(6):1144-50. doi: 10.1016/j.jaad.2014.09.012. Epub 2014 Oct 14.

引用本文的文献

1
Prevalence of Hidradenitis Suppurativa in Poland.波兰化脓性汗腺炎的患病率。
Dermatology. 2025 Jul 7:1-9. doi: 10.1159/000541951.
2
Prevalence of Hidradenitis Suppurativa in Dhaka, Bangladesh: A Hospital-Based Study.孟加拉国达卡化脓性汗腺炎的患病率:一项基于医院的研究。
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000538444.
3
A link between smoking behaviors and the risk of hidradenitis suppurativa in diabetic patients.吸烟行为与糖尿病患者化脓性汗腺炎风险之间的联系。
PLoS One. 2025 Jun 5;20(6):e0325357. doi: 10.1371/journal.pone.0325357. eCollection 2025.
4
Metabolic syndrome and dermatological diseases: association and treatment.代谢综合征与皮肤病:关联与治疗
Nutr Metab (Lond). 2025 May 6;22(1):36. doi: 10.1186/s12986-025-00924-1.
5
The Therapeutic Potential of GLP-1 Receptor Agonists in the Management of Hidradenitis Suppurativa: A Systematic Review of Anti-Inflammatory and Metabolic Effects.胰高血糖素样肽-1受体激动剂在化脓性汗腺炎治疗中的潜力:抗炎和代谢作用的系统评价
J Clin Med. 2024 Oct 22;13(21):6292. doi: 10.3390/jcm13216292.
6
Demographic Data, Risk Factors, and Disease Burden of HS Patients in Lithuania at a Reference Center.立陶宛某参考中心HS患者的人口统计学数据、风险因素及疾病负担
Healthcare (Basel). 2024 Sep 14;12(18):1849. doi: 10.3390/healthcare12181849.
7
Improving hidradenitis suppurativa management: consensus statements from physicians and patients' perspectives.改善化脓性汗腺炎的管理:来自医生和患者视角的共识陈述。
Arch Dermatol Res. 2024 Aug 24;316(8):577. doi: 10.1007/s00403-024-03316-2.
8
Metabolic endoscopy and a simplified low-carbohydrate-high-dietary fiber template as novel treatments for hidradenitis suppurativa - A case series.代谢内镜检查及简化的低碳水化合物高膳食纤维模式作为化脓性汗腺炎的新治疗方法——病例系列
JAAD Case Rep. 2023 Feb 19;34:23-26. doi: 10.1016/j.jdcr.2023.01.035. eCollection 2023 Apr.
9
Incidence, Risk Factors, and Prognosis of Hidradenitis Suppurativa Across the Globe: Insights from the Literature.全球化脓性汗腺炎的发病率、危险因素及预后:文献综述
Clin Cosmet Investig Dermatol. 2023 Mar 2;16:545-552. doi: 10.2147/CCID.S402453. eCollection 2023.
10
Alterations of the Human Gut Microbiome in Patients With Hidradenitis Suppurativa: A Case-control Study and Review of the Literature.化脓性汗腺炎患者肠道微生物群的改变:一项病例对照研究及文献综述
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022191. doi: 10.5826/dpc.1204a191. eCollection 2022 Nov.